Brewers' Bullpen Strategy: A Tale of Injury and Opportunity
The Milwaukee Brewers have made a strategic move, activating left-hander Rob Zastryzny from the 60-day injured list and optioning righty Carlos Rodriguez to Triple-A. This decision comes as the team navigates the challenges of managing a robust bullpen and addressing the recent setbacks of Angel Zerpa, who has been placed on the 60-day IL following Tommy John surgery.
The Return of Zastryzny: A Serviceable Arm in a Strong Bullpen
Rob Zastryzny's return to the Brewers' bullpen is a significant development, especially considering his injury history. Since joining the team in 2024, Zastryzny has endured three extended injury absences, resulting in only 29 2/3 innings pitched. Despite this, his performance has been impressive, boasting a 2.12 ERA and a .580 OPS against opposing hitters. However, his low-90s fastball and 4.09 FIP suggest that his success may have been aided by good fortune and strong defensive support.
The Brewers' bullpen is a force to be reckoned with, currently ranked in the Top 10 in the Majors. Metrics such as strikeout rate, K-BB rate, groundball rate, and ERA all highlight the unit's prowess. Among the eight qualified relievers, only Trevor Megill and Jake Woodford have ERAs over 4.50, with Megill's strong peripherals indicating positive regression on the horizon. The presence of Aaron Ashby, who has accumulated nine wins, further solidifies the bullpen's strength.
Given Zastryzny's limited options, the pressure is on him to re-establish himself quickly. His serviceable arm, while not a premium back-end reliever, contributes to the team's overall depth and versatility in the bullpen.
Angel Zerpa's Long-Term Absence: A Setback and Opportunity
In contrast, Angel Zerpa's move to the 60-day IL is a more concerning development. Zerpa, who underwent Tommy John surgery a few weeks ago, will miss the entire 2026 season and a significant portion of 2027. This setback not only affects the team's immediate roster but also has long-term implications for Zerpa's career. With a $1.095MM salary in arbitration, his absence will be felt for years to come.
Despite the setback, Zerpa's groundball rate of 60.5% in 2024-25, the fifth-best among qualified relievers, showcases his potential. The opportunity to contribute a year and a half of serviceable relief before hitting free agency in 2028 provides a glimmer of hope for the team and Zerpa's future.
Implications and Future Outlook
The Brewers' strategic moves in the wake of these injuries highlight the delicate balance between managing a strong bullpen and addressing individual player setbacks. Zastryzny's return provides a boost to the bullpen, while Zerpa's absence serves as a reminder of the long-term investments required to maintain a competitive roster.
As the season progresses, the Brewers will need to navigate the challenges of maintaining their bullpen's strength while also addressing the long-term needs of players like Zerpa. The team's ability to adapt and make strategic decisions will be crucial in their pursuit of success in the highly competitive MLB landscape.
